"Johnson & Johnson has agreed to pay as much as $2.2 billion to
resolve an investigation into its marketing of the anti-psychotic drug
Risperdal, according to a published report."
Read article in the Houston Chronicle (USA)
Showing posts with label drug marketing. Show all posts
Showing posts with label drug marketing. Show all posts
Friday, July 27, 2012
Criminal fine for J & J drug company re Risperdal anti-psychotic
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";